These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 595698)

  • 1. [Toxic hepatoses due to Gravistat].
    Metzner C; Ziesenhenn K; Müller H; Kirsch WD
    Z Gesamte Inn Med; 1977 Aug; 32(16):407-8. PubMed ID: 595698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of toxic liver lesions due to Gravistat].
    Link H; Metzner C; Ziesenhenn K
    Z Gesamte Inn Med; 1978 Mar; 33(6):187-9. PubMed ID: 645155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI; Barinov AM; Prilepskaia VN
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract]   [Full Text] [Related]  

  • 5. Less estrogen in new oral contraceptive.
    Am J Nurs; 2003 Apr; 103(4):111-2. PubMed ID: 12677126
    [No Abstract]   [Full Text] [Related]  

  • 6. Three and one-half years' experience with a lower-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1976 Jun; 16(6):338-44. PubMed ID: 957360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemolytic-uremic syndrome caused by estrogen-progestagen combined oral contraceptives].
    Otero González A; Santos C; Jiménez JL; Gil J; Sánchez-Guisande D; Temes Montes XL
    Med Clin (Barc); 1984 May; 82(18):824. PubMed ID: 6429463
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efficacy, acceptability and metabolic effects of new low dose combined oral contraceptives.
    Bergstein NA
    Acta Obstet Gynecol Scand Suppl; 1976; 54():51-9. PubMed ID: 788446
    [No Abstract]   [Full Text] [Related]  

  • 9. Focal hemorrhagic necrosis of the liver. A clinicopathological entity possibly related to oral contraceptives.
    Zafrani ES; Pinaudeau Y; Le Cudonnec B; Julien M; Dhumeaux D
    Gastroenterology; 1980 Dec; 79(6):1295-9. PubMed ID: 7439635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cholestatic jaundice following ovulation inhibitors].
    Kaess H; Fritsch H
    Geburtshilfe Frauenheilkd; 1969 Mar; 29(3):213-8. PubMed ID: 5777587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
    Albus C; Männchen E
    Zentralbl Gynakol; 1987; 109(8):521-6. PubMed ID: 3111130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Massive, painful hepatomegaly, sinusoidal dilatation and prolonged use of estroprogestational agents].
    Fischer D; Kémény F; Rauturseau J; Marty M; Karsenti P
    Gastroenterol Clin Biol; 1982 Mar; 6(3):302-4. PubMed ID: 7095347
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-oestrogen combined oral contraceptive.
    Foss GL; Fotherby K
    Acta Eur Fertil; 1973 Jun; 4(2):57-8. PubMed ID: 4784140
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of combined contraceptive preparations of Hungarian manufacture].
    Farkas M
    Akush Ginekol (Mosk); 1983 Nov; (11):11-4. PubMed ID: 6364870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the coadministration of daclatasvir on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate.
    Bifano M; Sevinsky H; Hwang C; Kandoussi H; Jiang H; Grasela D; Bertz R
    Antivir Ther; 2014; 19(5):511-9. PubMed ID: 24343001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
    Milchev N; Terzhumanov R; Grozdanov G; Krumov G
    Akush Ginekol (Sofiia); 1992; 31(2):42-3. PubMed ID: 1342561
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral contraception, 1986. Focus on Triphasil.
    Ellsworth H
    J Reprod Med; 1986 Jun; 31(6 Suppl):559-64. PubMed ID: 3522896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contraceptive patch. Latest developments.
    Courtney K
    AWHONN Lifelines; 2006; 10(3):250-4. PubMed ID: 16792714
    [No Abstract]   [Full Text] [Related]  

  • 20. Chinical experience with levonorgestrel and ethinyl estradiol in Beijing.
    Weng LJ; Gu SJ
    Chin Med J (Engl); 1987 Mar; 100(3):219-23. PubMed ID: 3113845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.